Published in Am J Respir Crit Care Med on January 15, 2011
Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis. Am J Respir Crit Care Med (2010) 2.04
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med (2012) 4.69
Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis. Clin Infect Dis (2014) 2.75
T-Spot.TB outperforms tuberculin skin test in predicting tuberculosis disease. Am J Respir Crit Care Med (2010) 2.36
Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong. Chest (2003) 1.65
Targeting persisters for tuberculosis control. Antimicrob Agents Chemother (2012) 1.65
Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses. Antimicrob Agents Chemother (2011) 1.62
Antituberculosis drugs and hepatotoxicity. Respirology (2006) 1.62
Risk of active tuberculosis among schoolchildren in Hong Kong. Arch Pediatr Adolesc Med (2006) 1.52
The current role of thoracic surgery in tuberculosis management. Respirology (2009) 1.52
Lethal interaction: the colliding epidemics of tobacco and tuberculosis. Expert Rev Anti Infect Ther (2007) 1.41
Lung function testing prediction equations: do they fit all? Chest (2008) 1.37
Seasonal pattern of tuberculosis in Hong Kong. Int J Epidemiol (2005) 1.35
Tuberculosis in the global aging population. Infect Dis Clin North Am (2010) 1.34
Treatment of tuberculosis and optimal dosing schedules. Thorax (2010) 1.13
Current development and future prospects in chemotherapy of tuberculosis. Respirology (2010) 1.12
Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother (2010) 1.02
Management of multidrug-resistant tuberculosis: Update 2007. Respirology (2008) 1.01
Exposure to avian influenza H7N9 in farms and wet markets. Lancet (2013) 1.00
Experimental models of tuberculosis: can we trust the mouse? Am J Respir Crit Care Med (2009) 0.96
Household contact investigation of tuberculosis in low-income and middle-income countries: public-health impact. Lancet Infect Dis (2009) 0.96
Systematic review of interferon-gamma release assays in tuberculosis: focus on likelihood ratios. Thorax (2010) 0.95
Reexamining the role of radiography in tuberculosis case finding. Int J Tuberc Lung Dis (2011) 0.94
The association between symptoms and microbiologically defined response to tuberculosis treatment. Ann Am Thorac Soc (2013) 0.92
Genetic association between a chemokine gene CXCL-10 (IP-10, interferon gamma inducible protein 10) and susceptibility to tuberculosis. Clin Chim Acta (2009) 0.90
Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD). Int J Chron Obstruct Pulmon Dis (2013) 0.90
Association of polymorphisms in the Chr18q11.2 locus with tuberculosis in Chinese population. Hum Genet (2013) 0.90
Prognostic significance of early weight gain in underweight patients with tuberculosis. Am J Respir Crit Care Med (2006) 0.89
Further evidence for a link between silica dust and esophageal cancer. Int J Cancer (2005) 0.88
Initial experience on rifampin and pyrazinamide vs isoniazid in the treatment of latent tuberculosis infection among patients with silicosis in Hong Kong. Chest (2003) 0.88
Protease inhibitor phenotypes and serum alpha-1-antitrypsin levels in patients with COPD: a study from Hong Kong. Respirology (2004) 0.87
Update in tuberculosis 2008. Am J Respir Crit Care Med (2009) 0.84
A strong tuberculin reaction in primary school children predicts tuberculosis in adolescence. Pediatr Infect Dis J (2012) 0.83
Comparison of intracellular cytokine flow cytometry and an enzyme immunoassay for evaluation of cellular immune response to active tuberculosis. Clin Vaccine Immunol (2009) 0.83
Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus-infected persons. Respirology (2013) 0.83
Delayed sternotomy wound infection due to Paecilomyces variotii in a lung transplant recipient. J Heart Lung Transplant (2002) 0.82
Update in tuberculosis 2007. Am J Respir Crit Care Med (2008) 0.82
Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city. Eur Respir J (2012) 0.81
Update in tuberculosis 2005. Am J Respir Crit Care Med (2006) 0.80
Active tuberculosis case finding: why, when and how? Int J Tuberc Lung Dis (2013) 0.79
Does metabolic syndrome cause obstructive sleep apnoea? Respir Med (2007) 0.79
Year in review 2014: Lung cancer, pleural diseases, respiratory infections and tuberculosis, bronchoscopic intervention and imaging. Respirology (2015) 0.78
Corticosteroid administration and treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA (2010) 0.78
Acetaminophen and asthma: spurious association? Am J Respir Crit Care Med (2011) 0.78
Diagnosing tuberculosis in patients with HIV: do we know enough? Am J Respir Crit Care Med (2009) 0.78
Multidrug-resistant tuberculosis in a lung transplant recipient. J Heart Lung Transplant (2003) 0.78
T-Spot.TB outperforms tuberculin skin test in predicting development of active tuberculosis among household contacts. Respirology (2015) 0.77
Harnessing the full sterilising activity of rifamycins. Int J Tuberc Lung Dis (2011) 0.77
Treatment of tuberculosis in HIV-infected patients: we need to know more. Am J Respir Crit Care Med (2007) 0.77
The best approach to reintroducing tuberculosis treatment after hepatotoxicity is still open to debate. Clin Infect Dis (2010) 0.77
Nutrient supplementation and tuberculosis treatment outcome. J Infect Dis (2009) 0.77
Update in tuberculosis 2006. Am J Respir Crit Care Med (2007) 0.76
Pacemaker infections due to rapidly growing mycobacteria: further experience. Int J Tuberc Lung Dis (2007) 0.76
Smoking and tuberculosis: infection, disease, and mortality. Arch Intern Med (2007) 0.76
Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection. Int J Tuberc Lung Dis (2006) 0.76
How are we creating fluoroquinolone-resistant tuberculosis? Am J Respir Crit Care Med (2009) 0.76
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis. J Antimicrob Chemother (2009) 0.76
Tuberculosis, nontuberculous lung infection, pleural disorders, pulmonary function, respiratory muscles, occupational lung disease, pulmonary infections, and social issues in AJRCCM in 2004. Am J Respir Crit Care Med (2005) 0.76
Is the whole-blood gamma interferon assay better than the tuberculin skin test in predicting active tuberculosis? Am J Respir Crit Care Med (2008) 0.75